Ligand validation:3FXX

ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER

ANP is a Ligand Of Interest in 3FXX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3FXX_ANP_A_992	55%	32%	0.11	0.877	1.16	1.51	2	4	0	0	100%	0.871
2QO7_ANP_A_1000	54%	17%	0.115	0.879	1.82	1.8	8	8	0	0	100%	0.971
2QOC_ANP_A_949	50%	1%	0.133	0.882	1.75	6.52	7	6	1	0	100%	0.8323
2QOQ_ANP_A_948	34%	16%	0.149	0.829	1.84	1.83	8	8	0	0	100%	0.9516
2QO9_ANP_A_948	27%	15%	0.157	0.801	1.89	1.92	8	6	0	0	100%	0.8226
8PS7_ANP_A_704	100%	43%	0.023	0.994	1.15	1.05	4	2	0	0	100%	1
9AVR_ANP_A_501	100%	36%	0.034	0.991	1.05	1.46	2	5	2	0	100%	1
4BRA_ANP_A_1394	100%	12%	0.037	0.993	2.3	1.8	10	6	3	0	100%	1
4DFX_ANP_E_402	100%	32%	0.036	0.989	1.35	1.35	4	2	1	0	100%	1
4BRD_ANP_B_1396	100%	16%	0.041	0.994	1.66	2.04	4	10	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.